Medpage Today on MSN
First Survival Win for CDK4/6 Inhibitors in High-Risk Early-Breast Cancer
BERLIN -- For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall ...
Opinion
5hOpinion
Letters: Federal government’s ‘crime-fighting’ strategy is making Chicago domestic violence survivors less safe
Like an abusive partner, the federal government is isolating domestic violence survivors by making help-seeking scarier and riskier.
Lennar's consensus analyst price target has recently edged down from $129.07 to $127.50. This reflects a modest reduction of ...
SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced positive topline results from the ...
Despite the U.S. government shutdown, the Education Department will continue to process the FAFSA. If it's your first time ...
Gilead Sciences, Inc. (Nasdaq: GILD) today shared positive data from the Phase 3 ASCENT-03 study demonstrating a highly statistically significant and clinically meaningful improvement in ...
Pfizer Inc. (NYSE: PFE) today announced updated follow-up results from the single-arm Phase 2 PHAROS trial evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback